Cargando…
PLA2R-IgG4 antibody as a predictive biomarker of treatment effectiveness and prognostic evaluation in patients with idiopathic membranous nephropathy: a retrospective study
BACKGROUND: The Kidney Disease Improving Global Outcomes (KDIGO) 2021 guidelines recommend Rituximab (RTX) as the first-line therapy and phospholipase A2 receptor (PLA2R) antibody as a biomarker for remission and prognosis in patients with idiopathic membranous nephropathy (IMN). METHODS: This study...
Autores principales: | Huang, Yiqing, Zhou, Junyi, Zhou, Kezhi, Huang, Biao, Xue, Jing, Zhang, Xiran, Liu, Bin, Zhang, Zhijian, Zhou, Leting, Cai, Ting, Zhang, Yi, Hu, Zhigang, Wang, Liang, Liu, Xiaobin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PeerJ Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9559058/ https://www.ncbi.nlm.nih.gov/pubmed/36248712 http://dx.doi.org/10.7717/peerj.14193 |
Ejemplares similares
-
A PLA2R-IgG4 Antibody-Based Predictive Model for Assessing Risk Stratification of Idiopathic Membranous Nephropathy
por: Liu, Xiaobin, et al.
Publicado: (2021) -
Clinical Evaluation of Antiphospholipase A2 Receptor IgG4 level and Its IgG4-to-IgG Ratio Based on Quantitative Immunoassays in Idiopathic Membranous Nephropathy
por: Zhang, Yi, et al.
Publicado: (2022) -
Idiopathic membranous nephropathy and IgG4: an interesting relationship
por: Filippone, Edward J.
Publicado: (2014) -
Definition of IgG Subclass-Specific Glycopatterns in Idiopathic Membranous Nephropathy: Aberrant IgG Glycoforms in Blood
por: Chinello, Clizia, et al.
Publicado: (2022) -
Glomerular IgG subclasses in idiopathic and malignancy-associated membranous nephropathy
por: Lönnbro-Widgren, Jennie, et al.
Publicado: (2015)